Abbott Stock Screener | Share Price & Fundamental Analysis
ABBOTINDIA
Pharmaceuticals
Screen Abbott share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹28155.00
▲
30.00 (0.11%)
Share Price BSE
₹28177.35
▲
76.20 (0.27%)
Market Cap
₹60,677.38 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
15.40
EPS (TTM)
₹665.62
Dividend Yield
1.63%
Debt to Equity
0.04
52W High
₹35670.00
52W Low
₹25501.85
Operating Margin
27.00%
Profit Margin
21.54%
Revenue (TTM)
₹7,005.00
EBITDA
₹2,103.00
Net Income
₹1,509.00
Total Assets
₹5,917.00
Total Equity
₹4,233.00
Abbott Share Price History - Stock Screener Chart
Screen ABBOTINDIA historical share price movements with interactive charts. Analyze price trends and patterns.
Abbott Company Profile - Fundamental Screener
Screen Abbott company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ABBOTINDIA shares.
Abbott India Ltd is a leading multinational pharmaceutical company in India. It operates an owned manufacturing facility in Goa and works with various independent contract manufacturers across the country. The company sells its products primarily within India through independent distributors. Abbott India provides pharmaceutical products and solutions across various therapeutic areas including Women's Health, Gastroenterology, Central Nervous System, Metabolics, Multi-Specialty, Vaccines, and Consumer Health. The company is structured into four divisions: Primary Care, Specialty Care-Methabolics and Urology, Specialty Care-Neuroscience, and Hospital Care. Abbott India manufactures and markets a wide range of products including Brufen, Prothiaden, Thyronorm, Leptos, Digene, Cremaffin, Influvac, and many others. The company has expanded its product portfolio through launches, acquisitions, and partnerships over the years. Abbott India is engaged in research and development, conducting clinical studies and publishing in medical journals. The company has also been recognized for innovation in the pharmaceutical industry.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
Chairperson/CEO
Munir Shaikh
ISIN
INE358A01014
Website
https://www.abbott.co.in
Abbott Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen ABBOTINDIA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 5,917 | 5,194 | 4,556 | 4,224 | 3,840 | 3,547 | 2,941 | 2,416 | 2,066 | 1,617 |
| Current Assets | 4,742 | 3,246 | 3,025 | 3,853 | 3,487 | 3,205 | 2,761 | 2,266 | 1,893 | 1,451 |
| Fixed Assets | 336 | 225 | 237 | 271 | 251 | 270 | 105 | 81 | 110 | 109 |
| Liabilities | ||||||||||
| Total Liabilities | 5,917 | 5,194 | 4,556 | 4,224 | 3,840 | 3,547 | 2,941 | 2,416 | 2,066 | 1,617 |
| Current Liabilities | 277 | 152 | 161 | 201 | 207 | 224 | 75 | 55 | 47 | 39 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 4,233 | 3,699 | 3,189 | 2,820 | 2,602 | 2,432 | 2,009 | 1,693 | 1,387 | 1,196 |
| Share Capital | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 |
| Reserves & Surplus | 4,212 | 3,678 | 3,167 | 2,799 | 2,581 | 2,410 | 1,987 | 1,672 | 1,366 | 1,174 |
Screen ABBOTINDIA income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7,005 | 6,685 | 6,097 | 5,503 | 4,997 | 4,391 | 4,208 | 3,792 | 3,416 | 2,960 | 2,665 | 2,337 |
| Expenses | 4,902 | 4,715 | 4,396 | 4,143 | 3,832 | 3,389 | 3,337 | 3,074 | 2,774 | 2,505 | 2,250 | 1,977 |
| EBITDA | 2,103 | 1,970 | 1,701 | 1,360 | 1,165 | 1,002 | 871 | 718 | 642 | 455 | 415 | 360 |
| Operating Profit % | 27.00% | 26.00% | 25.00% | 23.00% | 22.00% | 21.00% | 18.00% | 16.00% | 16.00% | 14.00% | 14.00% | 13.00% |
| Depreciation | 74 | 72 | 71 | 70 | 66 | 58 | 60 | 17 | 16 | 16 | 14 | 15 |
| Interest | 20 | 11 | 12 | 16 | 19 | 18 | 9 | 2 | 4 | 2 | 3 | 1 |
| Profit Before Tax | 2,009 | 1,887 | 1,618 | 1,274 | 1,080 | 926 | 803 | 699 | 622 | 437 | 398 | 344 |
| Tax | 497 | 473 | 417 | 324 | 281 | 235 | 210 | 249 | 220 | 160 | 143 | 115 |
| Net Profit | 1,509 | 1,414 | 1,201 | 949 | 799 | 691 | 593 | 450 | 401 | 277 | 255 | 229 |
| EPS | 710.10 | 665.62 | 565.28 | 446.80 | 375.87 | 325.04 | 279.04 | 211.93 | 188.81 | 130.19 | 120.12 | 107.75 |
Abbott Cash Flow Screener - Liquidity Fundamentals
Screen ABBOTINDIA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 1,012 | 1,213 | 893 | 948 | 727 | 626 | 499 | 153 | 307 | 249 |
| Investing Activities | 182 | -416 | -148 | -396 | -72 | -401 | -257 | -215 | -155 | -77 |
| Financing Activities | -925 | -745 | -639 | -637 | -582 | -217 | -143 | -102 | -90 | -80 |
| Net Cash Flow | 269 | 52 | 107 | -86 | 73 | 8 | 99 | -165 | 62 | 91 |
Screen ABBOTINDIA shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% | 74.99% |
| FII Holding | 0.16% | 0.16% | 0.16% | 0.18% | 0.18% | 0.16% | 0.16% | 0.00% |
| DII Holding | 8.92% | 9.19% | 9.11% | 8.91% | 8.81% | 8.99% | 9.01% | 8.62% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 13.66% | 13.35% | 13.43% | 13.80% | 13.86% | 13.65% | 13.59% | 14.07% |
| Other Holding | 2.28% | 2.31% | 2.31% | 2.12% | 2.16% | 2.21% | 2.25% | 2.32% |
| Shareholder Count | 69,934 | 67,584 | 71,199 | 69,382 | 71,588 | 69,449 | 67,892 | 72,086 |
Abbott Dividend Screener - Share Yield Analysis
Screen ABBOTINDIA dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹475.00 | 1.64% |
| 2024-March | ₹410.00 | 1.33% |
| 2023-March | ₹325.00 | 1.20% |
| 2022-March | ₹275.00 | 1.26% |
| 2021-March | ₹275.00 | 1.55% |
| 2020-March | ₹250.00 | 1.67% |
| 2019-March | ₹65.00 | 0.42% |
| 2018-March | ₹55.00 | 0.75% |
| 2017-March | ₹40.00 | 0.73% |
Abbott Index Membership - Market Screener Classification
Screen ABBOTINDIA by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Abbott Market Events Screener - Corporate Actions
Screen ABBOTINDIA market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-11-06 | 2025-11-06 | Quarterly Result Announcement | NA | -1.36% |
| 2025-08-13 | 2025-08-13 | Annual General Meeting | NA | 6.57% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | -1.83% |
| 2025-07-25 | 2025-07-25 | Dividend | ₹ 475.00 /share | 13.94% |
| 2025-05-15 | 2025-05-15 | Quarterly Result Announcement | NA | 0.67% |
| 2025-02-05 | 2025-02-05 | Quarterly Result Announcement | NA | -1.42% |
| 2024-11-07 | 2024-11-07 | Quarterly Result Announcement | NA | 2.06% |
| 2024-08-08 | 2024-08-08 | Annual General Meeting | NA | 8.45% |
| 2024-07-19 | 2024-07-19 | Dividend | ₹ 410.00 /share | 10.98% |
| 2023-07-21 | 2023-07-21 | Dividend | ₹ 180.00 /share | 12.85% |
| 2023-07-21 | 2023-07-21 | Dividend | ₹ 145.00 /share | 12.85% |
| 2022-08-02 | 2022-08-04 | Dividend | ₹ 145.00 /share | 24.76% |
| 2022-08-02 | 2022-08-04 | Dividend | ₹ 130.00 /share | 24.76% |
| 2021-07-19 | 2021-07-21 | Dividend | ₹ 155.00 /share | 7.42% |
| 2021-07-19 | 2021-07-21 | Dividend | ₹ 120.00 /share | 7.42% |
Abbott Competitors Screener - Peer Comparison
Screen ABBOTINDIA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 412,542 | 39.35 | 54,729 | 9.71% | 10,980 | 38.94 |
| Divis Laboratories | 167,550 | 68.31 | 9,712 | 18.67% | 2,191 | 47.61 |
| Torrent Pharmaceuticals | 129,963 | 60.76 | 11,539 | 6.99% | 1,911 | 63.27 |
| Cipla | 121,125 | 22.46 | 28,410 | 7.12% | 5,291 | 50.85 |
| Dr Reddys Laboratories | 104,396 | 18.49 | 33,741 | 16.73% | 5,725 | 53.02 |
| Lupin | 95,983 | 22.19 | 22,910 | 13.74% | 3,306 | 57.47 |
| Zydus Life Science | 91,914 | 18.30 | 23,511 | 18.55% | 4,615 | 43.59 |
| Mankind Pharma | 89,537 | 51.11 | 12,744 | 20.90% | 2,007 | 49.10 |
| Aurobindo Pharma | 68,790 | 20.05 | 32,346 | 9.43% | 3,484 | 45.26 |
| Alkem Laboratories | 65,288 | 27.31 | 13,458 | 3.70% | 2,216 | 41.76 |
Abbott Company Announcements - News Screener
Screen ABBOTINDIA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-06 | Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015. | View |
| 2025-12-31 | Announcement under Regulation 30 (LODR)-Change in Directorate | View |
| 2025-12-19 | Closure of Trading Window | View |
| 2025-11-25 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-11-24 | Approval Of Central Government For Appointment Of Managing Director | View |
| 2025-11-07 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-06 | Unaudited Financial Results For The Quarter Ended September 30 2025. | View |
| 2025-11-06 | Board Meeting Outcome for Outcome Of Board Meeting | View |
| 2025-10-29 | Board Meeting Intimation for Intimation Under Regulation 29(1)(A) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015. | View |
| 2025-10-15 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |
| 2025-10-13 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-08 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-09-25 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-09-24 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-09-24 | Closure of Trading Window | View |
| 2025-09-12 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-09-11 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | View |
| 2025-08-14 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-08-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-13 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |